Insiders · Profile

HANNAH ALISON L.

Chief Medical Officer at CytomX Therapeutics · Director at NEOGENOMICS. Filing since 3 Mar 2016. CIK 0001645600

Company

Date

Role

Action

Amount

Of holding

20 Jul 2022

Chief Medical Officer

Sold, plan not stated

5,602

$7.97K

14.9%

27 Jul 2017

Director

Bought

20,000

$183.80K

106%

3 Mar 2016

Director

Bought

10,000

$69.00K

641%

3 decisions on file.